Skip to content

Feeding Trial in the Obese Critical Care Population

Enteral Formula Tolerance in the Obese Critical Care Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01357200
Enrollment
26
Registered
2011-05-20
Start date
2011-05-31
Completion date
2013-12-31
Last updated
2014-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Obesity

Brief summary

This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.

Detailed description

Assess enteral feeding goal with a higher protein whey based peptide formula in an obese critically ill population.

Interventions

Complete feeding of study enteral formula, route and regime prescribed by the physician.

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Surgical or Medical intensive care unit (ICU) patient * Body mass index (BMI) ≥ 30

Exclusion criteria

* pregnant or lactating * unable to access gastrointestinal (GI) tract for feeding via tube * other contraindication to tube feeding * admitted with burns * severe head trauma

Design outcomes

Primary

MeasureTime frameDescription
time to feeding goal achievementup to 5 dayson all participants

Secondary

MeasureTime frameDescription
gastrointestinal measures assessmentdaily for up to 11 dayson all participants
percent of nutrition goal metup to 5 dayson all participants
serum biochemical markers assessmentdaily for up to 11 dayson all participants
assessment of frequency and nature of adverse eventsdaily for up to 11 dayson all participants

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026